Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04809805
Title A Study to Learn How Safe BAY2666605 is, How it Affects the Body, How it Moves Into, Through and Out of the Body, the Maximum Amount That Can be Given and Its Action Against Tumors in Adult Participants With Skin Cancer That Has Spread to Other Parts of the Body and Other Types of Advanced Cancer
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Bayer
Indications

fallopian tube cancer

glioblastoma

peritoneum cancer

melanoma

anaplastic astrocytoma

ovary epithelial cancer

Therapies

BAY2666605

Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Yale University School of Medicine Not yet recruiting New Haven Connecticut 06510 United States Details
Massachusetts General Hospital Suspended Boston Massachusetts 02114 United States Details
Dana-Farber Cancer Institute Suspended Boston Massachusetts 02215-5450 United States Details
Beth Israel Deaconess Medical Center Suspended Boston Massachusetts 02215 United States Details
Mayo Clinic - Rochester Withdrawn Rochester Minnesota 55905 United States Details
Sarah Cannon Development Innovations Recruiting Nashville Tennessee 37203 United States Details
University of Texas MD Anderson Cancer Center Recruiting Houston Texas 77030 United States Details
South Texas Accelerated Research Therapeutics, LLC Recruiting San Antonio Texas 78229-3307 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field